-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KuYOQXCHqDHQZFADzusO9bB3nE+blDYfGA7Fj28nlz3/pI1FF5j5P+ozLBOAUQq0 IQ5RndU1E/hOcdQ3rEkTqA== 0000944209-01-000127.txt : 20010208 0000944209-01-000127.hdr.sgml : 20010208 ACCESSION NUMBER: 0000944209-01-000127 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010207 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CYPRESS BIOSCIENCE INC CENTRAL INDEX KEY: 0000716054 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222389839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-35589 FILM NUMBER: 1526593 BUSINESS ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE,SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 2062989400 MAIL ADDRESS: STREET 1: 401 QUEEN ANNE AVE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: IMRE CORP DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KRANZLER JAY D CENTRAL INDEX KEY: 0001055666 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194522323 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 SC 13G/A 1 0001.txt AMENDMENT NO. 2 TO SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Cypress Bioscience, Inc. ------------------------ (Name of Issuer) Common Stock, $.02 par value per share -------------------------------------- (Title of Class of Securities) 232674 10 1 ------------ (CUSIP Number) 12/31/00 -------- (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 4 pages - ------------------------------- ------------------------------ CUSIP No. 232674 10 1 13G Page 2 of 4 Pages - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) JAY D. KRANZLER - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 UNITED STATES - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 3,760.193 (1) SHARES ----------------------------------------------------------- BENEFICIALLY SHARED VOTING POWER OWNED BY 6 EACH 0 REPORTING ----------------------------------------------------------- PERSON SOLE DISPOSITIVE POWER WITH 7 3,385,867 (2) ----------------------------------------------------------- SHARED DISPOSITIVE POWER 8 0 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 3,760,193 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10 [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 7.2% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON 12 IN - ------------------------------------------------------------------------------ (1) Includes (a) 3,360,869 shares issuable to Reporting Person upon exercise of options to purchase common stock within 60 days of December 31, 2000, and (b) 374,326 shares held in the Issuer's 401(k) Plan, of which the Reporting person is a trustee. The Reporting Person disclaims beneficial ownership of the 374,326 shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities. (2) Excludes the 374,326 shares held in the Issuer's 401(k) Plan, of which the Reporting person does not have dispositive power. Page 2 of pages Item 1(a). Name of Issuer: Cypress Bioscience, Inc., a Delaware corporation ------------------------------------------------ Item 1(b). Address of Issuer's Principal Executive Offices: 4350 Executive Drive, Suite 325 ------------------------------- San Diego, CA 92121 -------------------- Item 2(a). Name of Person Filing: Jay D. Kranzler --------------- Item 2(b). Address of Principal Business Office or, if none, Residence: 4350 Executive Drive, Suite 325 ------------------------------- San Diego, CA 92121 -------------------- Item 2(c). Citizenship: United States ------------- Item 2(d). Title of Class of Securities: Common Stock ------------ Item 2(e). CUSIP Number: 232674 10 1 ----------- Item 3. Not applicable. Item 4. Ownership. (a) Amount Beneficially Owned: 3,760,193 shares, including (i) 3,360,869 shares issuable to ------------------------------------------------------------ Reporting Person upon exercise of options to purchase Common ------------------------------------------------------------ Stock within 60 days of 12/31/00, and (ii) 374,326 shares held in ----------------------------------------------------------------- the Issuer's 401(k) Plan, of which the Reporting person is the ---------------------------------------------------------- trustee. -------- (b) Percent of Class: 7.2% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 3,760,193 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 3,385,867 (iv) shared power to dispose or to direct the disposition of: 0 Page 3 of 4 pages Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [_] Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 31, 2001 ------------------------------------------- Date /s/ Jay D. Kranzler ------------------------------------------- Signature Jay D. Kranzler ------------------------------------------- Printed Name Page 4 of 4 pages -----END PRIVACY-ENHANCED MESSAGE-----